Search Within

Kylee Maclachlan

Formats
  1. Meeting Abstract (112)
  2. Journal Article (29)
  3. Review (5)
  4. Research Letter (3)
  5. Editorial (2)
Groups
  1. GME, Medicine (151)
  2. Graduate Medical Education (151)
  3. Department of Medicine (132)
  4. Hematologic Malignancies, Division of (128)
  5. Center for Hematologic Malignancies (126)
  6. Myeloma (126)

More Groups

People
  1. Saad Usmani (117)
  2. Alexander Lesokhin (107)
  3. Malin Hultcrantz (99)
  4. Neha Korde (91)
  5. Urvi Shah (90)
  6. Heather Landau (89)

More People

Years
  1. 2025 (2)
  2. 2024 (47)
  3. 2023 (45)
  4. 2022 (31)
  5. 2021 (15)
  6. 2020 (11)
Publications
  1. Blood (68)
  2. Clinical Lymphoma, Myeloma and Leukemia (39)
  3. Journal of Clinical Oncology (7)
  4. Blood Cancer Journal (6)
  5. Blood Advances (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (73)
  2. Elsevier Inc. (43)
  3. Nature Publishing Group (12)
  4. American Association for Cancer Research (7)
  5. American Society of Clinical Oncology (7)
  6. Royal College of Pathologists of Australasia (1)

More Publishers

Results (151)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
    Journal Article

    Maclachlan, K. H.; Rustad, E. H.; Derkach, A.; Zheng-Lin, B.; Yellapantula, V.; Diamond, B.; Hultcrantz, M.; Ziccheddu, B.; Boyle, E. M.; Blaney, P.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Positive selection as the unifying force for clonal evolution in multiple myeloma
    Research Letter

    Diamond, B.; Yellapantula, V.; Rustad, E. H.; Maclachlan, K. H.; Mayerhoefer, M.; Kaiser, M.; Morgan, G.; Landgren, O.; Maura, F.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Improving prognostic assignment in older age groups of multiple myeloma
    Meeting Abstract

    Boyle, E. M.; Litke, R. R.; Blaney, P.; Ashby, T. C.; Bauer, M.; Walker, B.; Ghamlouch, H.; Choi, J.; Perrial, E.; Wang, Y.; more...
    Journal of the American Geriatrics Society (2021)

    Fulltext@MSK | Save
  • Minimal residual disease in multiple myeloma: Defining the role of next generation sequencing and flow cytometry in routine diagnostic use
    Review

    Maclachlan, K. H.; Came, N.; Diamond, B.; Roshal, M.; Ho, C.; Thoren, K.; Mayerhoefer, M. E.; Landgren, O.; Harrison, S.
    Pathology (2021)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
    Journal Article

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Leongamornlert, D.; Abascal, F.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Geerdens, E.; Diamond, B. T.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
    Review

    Diamond, B. T.; Rustad, E.; Maclachlan, K.; Thoren, K.; Ho, C.; Roshal, M.; Ulaner, G. A.; Landgren, C. O.
    Blood Reviews (2021)

    Fulltext@MSK | Save